- Report
- April 2025
- 130 Pages
Global
From €4258EUR$4,850USD£3,724GBP
- Report
- April 2025
- 79 Pages
Global
From €15799EUR$17,995USD£13,819GBP
- Report
- April 2025
- 130 Pages
Global
From €4258EUR$4,850USD£3,724GBP
- Report
- March 2025
- 74 Pages
Global
From €15799EUR$17,995USD£13,819GBP
- Report
- March 2025
- 179 Pages
Global
From €3951EUR$4,500USD£3,456GBP
- Report
- March 2025
- 130 Pages
Global
From €4258EUR$4,850USD£3,724GBP
- Report
- March 2025
- 155 Pages
Global
From €4258EUR$4,850USD£3,724GBP
- Report
- October 2025
- 100 Pages
United States
From €5224EUR$5,950USD£4,569GBP
- Report
- June 2025
- 80 Pages
United States
From €5224EUR$5,950USD£4,569GBP
- Report
- June 2025
- 83 Pages
United States
From €5224EUR$5,950USD£4,569GBP
- Report
- June 2025
- 80 Pages
United States
From €5224EUR$5,950USD£4,569GBP
- Report
- November 2025
- 67 Pages
Asia Pacific
From €2853EUR$3,250USD£2,496GBP
- Report
- November 2025
- 69 Pages
Europe
From €2853EUR$3,250USD£2,496GBP
- Report
- August 2025
- 122 Pages
North America
From €3511EUR$3,999USD£3,071GBP
- Report
- February 2026
- 150 Pages
United States
From €3380EUR$3,850USD£2,956GBP
€4258EUR$4,850USD£3,724GBP
- Report
- February 2026
- 210 Pages
United States
From €3380EUR$3,850USD£2,956GBP
€4258EUR$4,850USD£3,724GBP
- Report
- December 2025
- 150 Pages
United States
From €3380EUR$3,850USD£2,956GBP
€4258EUR$4,850USD£3,724GBP
- Report
- October 2025
- 89 Pages
United States
From €4258EUR$4,850USD£3,724GBP
- Report
- October 2025
- 90 Pages
Middle East
From €4258EUR$4,850USD£3,724GBP
- Report
- August 2025
- 81 Pages
Middle East, Africa
From €3029EUR$3,450USD£2,649GBP

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection.
The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more